RAPT Therapeutics, Inc.

NASDAQ:RAPT

0.8254 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -18.432-27.663-30.521-30.876-31.371-25.28-29.271-22.951-21.235-19.184-20.468-17.929-18.651-16.11-16.514-12.735-14.631-12.387-13.139-13.216-9.967-10.626-9.188-9.43-10.282-8.204-8.231
Depreciation & Amortization 0.2970.3050.3140.3230.3250.2690.2990.2520.260.2740.2610.2310.2290.2560.280.2650.2630.3960.1990.3190.3420.3380.3310.2940.3090.3220.312
Deferred Income Tax 000-5.146-1.564-2.16200000000012.72200000.02400-0.0330.0500
Stock Based Compensation 4.5645.3845.3984.4294.3294.2394.0943.0252.8652.6722.7022.0862.2912.8882.6872.5582.0052.0352.0880.8960.4310.3470.3770.2960.2940.2860.294
Change In Working Capital -4.083-6.016-1.876-0.995.814-6.4587.133-2.910.315-0.0991.359-5.4763.029-1.232-0.619-5.4992.2633.6731.9076.35-2.9910.926-0.152-0.3320.7690.3360.011
Accounts Receivables 0000000000000005.0105.01-5.0100000000
Change In Inventory 000000000000000-6.37600-0.56200000000
Change In Accounts Payables -4.394-6.427-0.728-0.0716.378-6.2497.277-0.2630.6731.4091.891-2.6183.080.1090.362-2.8173.396-0.612.421-1.451-0.9043.0420.049-0.0411.712-0.073-0.123
Other Working Capital 0.3110.411-1.148-0.919-0.564-0.209-0.144-2.647-0.358-1.508-0.532-2.858-0.051-1.341-0.981-1.316-1.1334.2835.0587.801-2.087-2.116-0.201-0.291-0.9430.4090.134
Other Non Cash Items 0.032-0.1646.3554.5060.5830.584-0.857-0.2650.6461.1420.5680.4070.5830.2820.256-12.6770.147-0.1440.2-0.0370.0220.002-0.002-0.006-0.003-0.002-0.003
Operating Cash Flow -17.622-28.154-27.084-27.754-21.884-28.808-18.602-22.849-17.149-15.195-15.578-20.681-12.519-13.916-13.91-15.366-9.953-6.427-8.745-5.688-12.139-9.013-8.634-9.211-8.863-7.262-7.617
Investing Activities:
Investments In Property Plant And Equipment -0.0170.001-0.105-0.067-0.066-0.233-0.759-0.049-0.081-0.566-0.149-0.394-0.07-0.064-0.227-0.174-0.1260-0.098-0.025-0.076-0.368-0.419-1.654-0.796-0.613-0.437
Acquisitions Net 000-20.706-25.815-32.67-26.06741.22117.5189.89200000800000000000
Purchases Of Investments -17.409-17.193-16.814-55.259-32.287-36.073-37.878-78.138-40.477-66.186-6.055-16.927-29.345-102.971-15.734-16.628-10.814-65.009-46.88300000000
Sales Maturities Of Investments 35.87136.40532.80675.96558.10268.74363.94536.91722.95956.29430.0411.42915.24139.34328.37232.297128000000000
Other Investing Activites 0015.99220.70625.81532.6726.067-41.221-17.518-9.89223.986-15.498-14.104-63.62812.638-81.1868-46.8830.0450000000
Investing Cash Flow 18.44519.21315.88720.63925.74932.43725.308-41.27-17.599-10.45823.837-15.892-14.174-63.69212.41115.4951.06-57.009-46.9810.02-0.076-0.368-0.419-1.654-0.796-0.613-0.437
Financing Activities:
Debt Repayment 000000000000000000000000000
Common Stock Issued 00.7018.9690.4580.1060.7670.11675.0254.97949.7840.1320.1880.472138.0921.184.0750.4110.45369.84234.7410.6820.0340.0660.0680.0620.0460.09
Common Stock Repurchased 000000000000000000000000000
Dividends Paid 000000000000000000000000000
Other Financing Activities 00.7010.0670.4580.1060.7670.1160.3340.2720.6540.1320.4130.4721.0160.1210.485-0.2460.8640.030-0.0197.4516.94745.176059.88-0.003
Financing Cash Flow 00.7019.0360.4580.1060.7670.11675.3595.25150.4380.1320.6010.472139.1081.3014.560.1650.86469.87234.7410.6637.4857.01322.6220.06229.9630.087
Other Information:
Effect Of Forex Changes On Cash 000-0.2010.358-0.157000000000000000000000
Net Change In Cash 0.823-8.24-2.161-6.6573.9714.3966.82211.24-29.49724.7858.391-35.972-26.22161.5-0.1984.689-8.728-62.57214.14629.073-11.552-1.896-2.0411.757-9.59722.088-7.967
Cash At End Of Period 37.937.07745.31747.47854.13550.16445.76838.94627.70657.20332.41824.02759.99986.2224.7224.91820.22928.95791.52977.38348.3159.86261.75863.79852.04161.63839.55